These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1801884)

  • 41. [Clinical study of HCFU in combination with irradiation therapy in squamous cell carcinoma of the head and neck].
    Harada T; Yamagiwa M; Kubo M; Ito Y; Fukukita K; Sakakura Y
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2538-43. PubMed ID: 3740856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
    Tsujie M; Nakamori S; Tanaka E; Nagano H; Umeshita K; Dono K; Sakon M; Inoue T; Inoue T; Monden M
    Jpn J Clin Oncol; 2006 Aug; 36(8):504-10. PubMed ID: 16855011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequential high-dose methotrexate, 5-fluorouracil, and doxorubicin for treatment of advanced pancreatic cancer.
    Scheithauer W; Funovics J; Mueller C; Ludwig H
    J Cancer Res Clin Oncol; 1990; 116(2):132-3. PubMed ID: 2324155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer.
    Mehta VK; Fisher GA; Ford JM; Oberhelman HA; Vierra MA; Bastidas AJ; Poen JC
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1483-7. PubMed ID: 11121652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil.
    Mawdsley S; Hall M; Glynne-Jones R
    Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):308-12. PubMed ID: 12206644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy for pancreatic cancer.
    Arbuck SG
    Baillieres Clin Gastroenterol; 1990 Dec; 4(4):953-68. PubMed ID: 2078794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
    Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy.
    Patel H; Stoller R; Auber M; Potter D; Cai C; Zamboni W; Kiefer G; Matin K; Schmotzer A; Ramanathan RK
    Invest New Drugs; 2006 Jul; 24(4):359-63. PubMed ID: 16525767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase II trial of topotecan in patients with previously untreated pancreatic cancer.
    O'Reilly S; Donehower RC; Rowinsky EK; Ord S; Grochow LB
    Anticancer Drugs; 1996 Jun; 7(4):410-4. PubMed ID: 8826609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma.
    Kruth J; Nissen J; Ernst T; Kripp M; Lukan N; Merx K; Hofmann WK; Hochhaus A; Hofheinz RD
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1845-51. PubMed ID: 20224968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.
    Ravandi F; Rytting ME; Osmon C; Braud EL; Roach RW; Edwards K; Winn R; Abbruzzese JL; Pazdur R
    Anticancer Drugs; 1999 Jul; 10(6):519-24. PubMed ID: 10885898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
    Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
    Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.
    Dutcher JP; Logan T; Gordon M; Sosman J; Weiss G; Margolin K; Plasse T; Mier J; Lotze M; Clark J; Atkins M
    Clin Cancer Res; 2000 Sep; 6(9):3442-50. PubMed ID: 10999727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma.
    Hsue V; Wong CS; Moore M; Erlichman C; Cummings BJ; MacLeod M
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):445-50. PubMed ID: 8567347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
    Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
    Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinoma.
    Bertheault-Cvitkovic F; Lévi F; Soussan S; Brienza S; Adam R; Itzhaki M; Misset JL; Bismuth H
    Eur J Cancer; 1993; 29A(13):1851-4. PubMed ID: 8260240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.
    Grem JL; McAtee N; Murphy RF; Balis FM; Cullen E; Chen AP; Hamilton JM; Steinberg SM; Quinn M; Sorensen JM; Arbuck SG; Lawrence D; Pang J; Allegra CJ
    Clin Cancer Res; 1997 Jul; 3(7):1125-34. PubMed ID: 9815792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.